Israel’s economy spans high-tech, pharmaceuticals, finance, chemicals, natural resources and telecommunications. As of 21 April 2026, we’ve ranked the largest publicly listed Israeli companies by market capitalisation, calculated as share price multiplied by total outstanding shares.
Below are the top 10 Israeli companies by market capitalisation as of 21 April 2026. Market capitalisations are shown in US dollars (USD), alongside each company’s share price.
| Rank | Company | Market cap (USD) | Share price (USD) |
|---|---|---|---|
| 1 | Elbit Systems | $39.8bn | $854.16 |
| 2 | Bank Leumi | $37.6bn | $25.44 |
| 3 | Teva Pharmaceutical Industries | $37.5bn | $31.40 |
| 4 | Bank Hapoalim | $35.2bn | $26.84 |
| 5 | Tower Semiconductor | $25.7bn | $215.59 |
| 6 | Mizrahi-Tefahot | $20.9bn | $80.48 |
| 7 | Azrieli Group | $19.3bn | $155.24 |
| 8 | Nova Ltd. | $16.8bn | $528.40 |
| 9 | The Phoenix Holdings | $14.9bn | $59.06 |
| 10 | Check Point Software | $14.8bn | $142.39 |
The information on this page is based on public company disclosures, including regulatory filings. It is provided for informational purposes only and does not constitute investment advice or a recommendation to trade. Figures are believed to be accurate as of the stated date, but may be updated without prior notice.
Elbit Systems' rise to the top of the ranking shows how defence demand can feed directly into market capitalisation when a company combines backlog growth, earnings expansion and a rerating in its valuation multiple. On 21 April 2026, Elbit traded at $858.99 with a market cap of about $40.0bn, and its shares were backed by a record $28.1bn backlog (Elbit Systems via Facebook, 17 March 2026), a recent $750m contract with Greece (Globes English, 6 April 2026; Army Technology, 7 April 2026), and strong full-year 2025 results, including revenue of $7.94bn and non-GAAP EPS of $3.56 in the fourth quarter.
This matters because market cap is not just about current profits; it also reflects how investors view future revenue visibility, contract duration and geopolitical demand. In Elbit's case, investors are effectively treating its order backlog and export contracts as a pipeline of future cash generation (StreetInsider, 10 April 2026), although the stock's elevated valuation and recent insider selling show that expectations can also become stretched.
Large Israeli banks remain near the top of the ranking because banks can build market value when interest rates, loan growth and fee income support profitability. Bank Leumi's market cap stood at 112.37bn ILA on 21 April 2026 (Stock Analysis, 21 April 2026), while Mizrahi Tefahot's was 62.49bn ILA and Bank Hapoalim's US-listed line carried a market cap of about $33.4bn (Yahoo Finance UK, 21 April 2026), showing how financials remain one of the core pillars of Israel's equity market.
The logic is straightforward: when rates stay relatively high, banks often earn a wider net interest margin between what they receive on loans and what they pay on deposits, which can support earnings and dividends. Because Israel's banking sector is concentrated among a handful of major institutions, investors often treat these names as proxies for the domestic economy, credit demand and household balance-sheet resilience.
Teva shows why market capitalisation in pharma depends heavily on what investors think the pipeline can become, rather than only what the company earns today. On 21 April 2026, Teva traded at $31.40 with a market cap of about $36.6bn, and sentiment was influenced by FDA approval of PONLIMSI, accepted filings for a proposed Xolair biosimilar (Stock Titan, 30 March 2026), a Blackstone-backed $400m funding deal for duvakitug (GlobeNewswire, 3 March 2026), and a consensus analyst target still above the current share price.
That is important because pharmaceutical shares are usually valued on a mix of present earnings, patent exposure, biosimilar launches, litigation risk and late-stage pipeline optionality. Teva's recent moves show this clearly: investors are balancing stronger specialty-drug and biosimilar prospects against insider selling, legal overhangs and the risk that future growth may already be partly priced in.
Israeli semiconductor-linked groups rank highly because their valuations are tied more to global capital-spending cycles than to domestic Israeli consumption. Tower Semiconductor traded at $213.55 on 21 April 2026 with a market cap of about $23.9bn (YCharts, 21 April 2026), while Nova traded at $532.05 with a market cap of about $16.9bn (Stock Analysis, 21 April 2026), highlighting the scale investors place on Israel's chip and process-control ecosystem.
This works through expectations for foundry utilisation, wafer-fab equipment spending, process complexity and customer demand from global chipmakers. When investors expect stronger semiconductor capital expenditure or greater demand for advanced process tools, companies such as Tower and Nova can gain market value quickly because their earnings are linked to longer-term technology investment cycles rather than short-term local market conditions.
Market capitalisation is calculated by multiplying a company’s current share price by its total number of shares in issue. It provides a quick way to compare the relative size of publicly listed companies.
To trade Israeli share CFDs, you’ll need an account with a regulated CFD provider that offers access to the Tel Aviv Stock Exchange or US-listed ADR CFDs. After verifying and funding your account, search for the relevant ticker symbol on the trading platform. You may wish to use a demo account first and apply risk management tools such as take-profit and stop-loss orders before trading with real funds. Remember that contracts for difference (CFDs) are traded on margin, and leverage amplifies both profits and losses.
Israeli companies are influenced by global technology trends, pharmaceutical approvals, defence contracts, interest rate policy and currency movements. Geopolitical developments in the Middle East also play a significant role. Past performance is not a reliable indicator of future results.
Some large Israeli banks and industrial firms pay regular dividend, while many technology companies reinvest earnings into growth. For the latest information, check each company’s investor relations page.
Great customer service I got to say that. They helped get my account back very fast, after i logged myself out by losing my old email, it was so fast you wouldn’t believe it thank you once again.
Everything worked as expected from the 1 day. I didn’t have to search how to use the platform, it’s intuitive. The support chat was there when I had a tiny issue.
Capital.com has been great for both learning and trading. The app is clean, fast, and packed with useful tools. Customer support has been solid too. Definitely recommended for beginners and active traders alike.
I trade every day and Capital is my beloved home. I also create music and you can always feel when something has been created from the heart. Capital has soul!
I would like to express a huge thank you to Evgeniya Logvinovich, customer service manager. For your attention and heartfelt attitude to your clients.❤️
I am extremely happy with this broker. Great spreads, good selection of instruments, well coded toolbox.
Love the TV integration. Makes traders life smooth and comfortable.
I trade every day and Capital is my beloved home. I also create music and you can always feel when something has been created from the heart. Capital has soul!
I’d been paper trading for 2yrs now, went live and this platform is easy for beginners to understand and navigate all important tools to execute all that I learned. Earning now!
This application is perfect.. simple, easy to use, run smoothly and fast and it has an accurate graphics.. be careful to use only one credit card and one bank account to prevent any withdrawal problem.. overnight fees and spread variation will be repaid for you by the next month.. I used many application but this is the best one
User friendly app & interface and good support team. Funds transfer ease & Leverage is an advantage but crypto is highly risky be responsible of your loss limits and risks appetite.
Capital is really great to be used on start, also beginner friendly broker! Great costumer support and it is quick!
Showing our 4 & 5 star reviews. The specific details of the user have been intentionally anonymised to safeguard their privacy pursuant to GDPR requirements.
Why choose Capital.com? Our numbers speak for themselves
Capital.com Group
Ratings and Reviews
Ratings and Reviews